Mindfulness Interventions and Cutaneous T Cell Lymphoma (CTCL)
The primary objective is to assess the feasibly, adherence, and effects of mindfulness-based stress reduction (MBSR) on anxiety and health-related quality of life in adult patients with cutaneous T-cell lymphoma at the Yale Cancer Center/Smilow Cancer Hospital.
Participants will attend group sessions led by an instructor experienced in MBSR in an academic setting. The mindfulness meditation group sessions will take place at the Smilow Cancer Center at the Yale New-Haven Hospital.
調査の概要
詳細な説明
Participants will attend weekly 2.5-hour group sessions (of 10-14 persons) based on the standard mindfulness-based stress reduction (MBSR) protocol. Participants will be assigned home practice based on the MBSR protocol, and will be given audio recordings (MP3) to accompany and instruct in home practice.
Eligible participants will attend weekly group sessions for 8 weeks and will be assessed at baseline, following cessation of the intervention (8-weeks), and 16 weeks. Outcomes will be assessed at baseline, 8 weeks, and 16 weeks. Extended effects of the intervention will be assessed at 16 weeks.
研究の種類
入学 (実際)
段階
- 適用できない
連絡先と場所
研究場所
-
-
Connecticut
-
New Haven、Connecticut、アメリカ、06511
- Yale Cancer Center/Smilow
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Identified with lymphoma through the Yale Cancer Center Hematology Clinic.
- Access to mobile telephone/smartphone with text messaging plan in order to receive survey questions.
- Current CTCL patients in Dr. Foss's practice at the Yale Cancer Center.
Exclusion Criteria:
- Current regular mindfulness meditation activity (weekly or more frequent practice of self-defined meditation, formalized relaxation techniques, tai chi, and meditative yoga).
- Inability or unwillingness to give consent.
- Serious illness (including mental illness/psychopathology) within 90 days prior to screening, including hospitalization for chronic disease. Determination of 'serious' will be made by PI and research team. For example, unstable asthma, cancers (except non-melanoma skin cancer and CTCL), and schizophrenia will be considered 'serious,' while stable asthma, allergic rhinitis, esophageal reflux, generalized anxiety disorder, or attention deficit disorder will not be considered 'serious.
- Active participation (weekly or more often) in a cancer or chronic disease support group.
- Active substance abusers.
- Current suicidal ideation, operationally defined as affirmative responses on the Columbia-Suicide Severity Rating Scale (C-SSRS) at screening.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：なし
- 介入モデル：単一グループの割り当て
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Mindfulness-Based Stress Reduction (MBSR)
Participants will attend group sessions led by an instructor experienced in MBSR in an academic setting.
|
Participants will attend weekly 2.5-hour group sessions (of 10-14 persons) based on the standard MBSR protocol.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Feasibility
時間枠：16 weeks
|
Feasibility of the intervention will be assessed by the proportion of eligible patients attend the majority of the MBSR sessions (5 or more), and complete week-8 and week-16 assessments.
|
16 weeks
|
|
Adherence
時間枠：16 weeks
|
Adherence will be tracked by assessing the actual amount of home practice in minutes per week using weekly practice logs and/or SMS (short message service)/text messaging.
Adherence will be quantitatively assessed through tallying home practice time and number of intervention visits attended.
|
16 weeks
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Stress
時間枠：baseline, 8 weeks, and 16 weeks
|
The Perceived Stress Scale (PSS) has been used in past Mindfulness treatment studies.
The PSS is a 14-item scale that assesses perceived stress of life situations in adolescents and adults.
Items are scored on a 5-point scale (0=never to 4=very often) (e.g., 'How often have you been upset because of something that happened unexpectedly?).
Higher total scores indicate greater levels of perceived stress.
|
baseline, 8 weeks, and 16 weeks
|
|
Quality of Life
時間枠：baseline, 8 weeks, and 16 weeks
|
The Functional Assessment of Cancer Therapy-General (FACT-G) is a cancer-focused measure of quality of life and well-being.
It is a standard assessment at the Yale Survivorship clinic.
It includes 27 items and encompasses 4 different indices of well-being: physical, social/family, emotional, and functional well-being and has been used to evaluate cancer-related QOL in many studies.
|
baseline, 8 weeks, and 16 weeks
|
その他の成果指標
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Depression
時間枠：baseline, 8 weeks, and 16 weeks
|
The Hospital Anxiety and Depression Scale (HADS) has been used to measure levels of anxiety and depression that a patient is experiencing.
The HADS has fourteen items, seven of which relate to anxiety and other seven of which related to depression.
Each item is scored on a 0-3 scale.
Higher total scores indicate greater levels of perceived anxiety/depression.
|
baseline, 8 weeks, and 16 weeks
|
|
Anxiety
時間枠：baseline, 8 weeks, and 16 weeks
|
The Hospital Anxiety and Depression Scale (HADS) has been used to measure levels of anxiety and depression that a patient is experiencing.
The HADS has fourteen items, seven of which relate to anxiety and other seven of which related to depression.
Each item is scored on a 0-3 scale.
Higher total scores indicate greater levels of perceived anxiety/depression.
|
baseline, 8 weeks, and 16 weeks
|
|
Healing
時間枠：baseline, 8 weeks, and 16 weeks
|
The Healing Encounters and Attitudes Lists (HEAL) questionnaires have been used to measure the nonspecific factors in healing process including patient-provider connection, treatment expectancy, healthcare environment, positive outlook, spirituality and attitude towards complementary and alternative medicine.
The HEAL item banks comprise six subscales, each of which has 6-7 questions.
Each item is scored on a 1-5 scale.
The HEAL measures have been well validated in integrative medicine research.
|
baseline, 8 weeks, and 16 weeks
|
|
Effect of Skin Disease
時間枠：baseline, 8 weeks, and 16 weeks
|
The Skindex-29 profiles are a 29-item measure that assesses the symptomatic, emotional, and functional effects of skin diseases on quality of life.
It is widely used in patients with nonmelanoma skin cancer including CTCL.
Items are scored based on how often (Never, Rarely, Sometimes, Often, All the time) during the previous four weeks the patient experienced the effect described in each item.
All responses are transformed to a linear scale of 100, varying from 0 (no effect) to 100 (effect experienced all the time).
|
baseline, 8 weeks, and 16 weeks
|
|
Client Credibility
時間枠：week 1
|
The Client Credibility Questionnaire (CCQ) will be used to assess subject expectations and beliefs about the mindfulness program at baseline using a questionnaire modeled after the methods of Sherman et al.
The CCQ will be administered to all subjects at the end of the first MBSR class, after the outline and rationale of the intervention has been presented.
Subjects will be asked to make ratings using an 8-point Likert scale (0= not at all to 8=very much) about: (1) how logical the program seems; (2) how confident they are the program will be successful in reducing symptoms; and (3) how confident they would be in recommending the program to a friend.
|
week 1
|
|
Suicide Severity
時間枠：screening/baseline
|
Columbia-Suicide Severity Rating Scale (C-SSRS) is a 2-item, self-report questionnaire that includes items suicidal ideations in the past week and the past year.
Questions include: (1) Have you wished you were dead or wished you could go to sleep and not wake up? and (2) Have you actually had any thoughts of killing yourself?
Any positive (yes) responses during the past week are immediately referred to Yale-New Haven Children's Hospital.
|
screening/baseline
|
|
Disease Progress
時間枠：baseline, 8 weeks, and 16 weeks
|
The Eastern Cooperative Oncology Group (ECOG) assessment will be used to assess how a patient's disease is progressing, assess how the disease affects the daily living abilities of the patient, and determine appropriate treatment and prognosis. ECOG is graded from 0 to 5. 0 = Fully active, able to carry on all pre-disease performance without restriction; 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, e.g., light house work, office work; 2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50% of waking hours; 3 = Capable of only limited selfcare, confined to bed or chair more than 50% of waking hours; 4 = Completely disabled. Cannot carry on any selfcare. Totally confined to bed or chair; 5 = Dead . |
baseline, 8 weeks, and 16 weeks
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
追加の関連 MeSH 用語
その他の研究ID番号
- 2000020161
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
生活の質の臨床試験
-
Hôpital Léon Bérard完了
-
Queens College, The City University of New York募集American Journal of Public Healthに投稿された論文の出版アメリカ
-
Swansea University完了A Bite of ACT' (BOA) Acceptance and Commitment Therapy オンライン心理教育コース | 待機リスト コントロールイギリス
-
University Hospital, Clermont-Ferrand積極的、募集していないMSProgress Qualityアプローチサポートツールの影響の評価標準ケアと比較して、MSPが選択したインジケーターの進化に及ぼすツールフランス
-
Scripps Translational Science Institute完了
-
Peking Union Medical College Hospitalまだ募集していません有効性と安全性 | 過敏性腸症候群 - 下痢 | N of 1 研究デザイン | 伝統的な中国医学 (TCM)中国